Samay’s AI-assisted wearable technology accurately diagnoses COPD
The device successfully diagnosed COPD in patients with 90% accuracy
Read More
Tag: chronic obstructive pulmonary disease
Verona publishes Phase II COPD results
Ensifentrine showed clinically and statistically significant improvements in lung function at all doses.
Read More
Boehringer to launch first reusable soft mist inhaler
Pharmacists are likely to see people with COPD and asthma more regularly than a GP or nurse, so they play a pivotal role in educating patients on their medicines and inhaler technique.
Read More
AZ’ triple combo hits endpoint in COPD trial
Breztri Aerosphere – formerly known as PT010 – showed a 52% reduction in exacerbations.
Read More
Verona Pharma share positive ensifentrine results in COPD
The trial consisted of 37 patients with moderate-to-severe COPD, who received a single dose of either the drug or a placebo.
Read More
Researchers to test heart drug for COPD patients
University of Aberdeen researchers are set to test beta-blockers for COPD patients.
Read More
AI app decreases symptoms of COPD, study finds
A new clinical study has found that Kaia Health’s artificial intelligence app successfully decreases symptoms of Chronic Obstructive Pulmonary Disease (COPD).
Read More
NICE turns down AZ’ Daxas for COPD
The National Institute for Health and Care Excellence has rejected AstraZeneca’s Daxas for use by the NHS in certain patients with chronic obstructive pulmonary disease (COPD).
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
